Today times what new added to the portfolio $CTLT (+3 %) and
No invitation to buy and no investment advice!
WKN US1488061029
Company name Catalent Inc
https://investor.catalent.com/financial-news/default.aspx
Founded 2007 IPO 2014
Country USA
Employees 19000
Investment type medium-term - long-term
Industry Health
Dividend none
P/E ratio currently 27.45
Sales 2019 2.51 billion USD
Sales 2020 3.09 billion USD
Sales 2021 3.99 billion USD
Sales 2022 4.82 billion USD
Revenue 2023 forecast up to $4.87 billion USD (Note that reporting segments started July 1, 2022 for Q1/2023)
A global leader enabling pharmaceutical, biotechnology and consumer health partners to optimize the development, launch and delivery of better patient treatments across multiple modalities.
It recently completed a 2800sqm expansion in China in the Waigaoqiao Free Trade Zone (FTZ).
Through its flexible manufacturing platforms in over 50 locations worldwide, deliver approximately 80 billion doses of nearly 8,000+ products annually.
What do you think of $XAIR (-0,93 %) ?
Ps. Followers wanted 😊
